Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Neutrophil-lookalike membranes fight arthritis

Sep. 10, 2018

Phase II TORTUGA trial of filgotinib in ankylosing spondylitis meets primary efficacy endpoint

Sep. 6, 2018

Phase III study of NeoCart in patients with knee cartilage damage does not meet the primary endpoint

Sep. 6, 2018

LEAPS rheumatoid arthritis vaccine selected for commercialization accelerator program

Sep. 6, 2018

Immutep advances development of LAG-3 agonist antibody IMP-761

Sep. 4, 2018

Update on TULIP 1 phase III trial for anifrolumab in systemic lupus erythematosus

Aug. 31, 2018

SLC10A7 gene mutations implicated in skeletal dysplasia

Aug. 30, 2018

Clinical trials completed for Celltrion's Remsima SC

Aug. 29, 2018

Polymorphisms in miRNA-146a and IRAK1 are associated with susceptibility to SLE and MS

Aug. 21, 2018

Let there be no light damage

Aug. 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...